KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 204 filers reported holding KURA ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $18,224,000 | -47.9% | 557,986 | -51.2% | 0.11% | -76.2% |
| Q3 2020 | $35,005,000 | +43.0% | 1,142,464 | -23.9% | 0.47% | +147.1% |
| Q2 2020 | $24,486,000 | -99.8% | 1,502,217 | 0.0% | 0.19% | +43.2% |
| Q1 2020 | $13,489,909,000 | -34.7% | 1,502,217 | 0.0% | 0.13% | -4.3% |
| Q4 2019 | $20,655,484,000 | +90538.0% | 1,502,217 | 0.0% | 0.14% | -13.2% |
| Q3 2019 | $22,789,000 | -23.0% | 1,502,217 | 0.0% | 0.16% | -21.7% |
| Q2 2019 | $29,578,000 | +18.7% | 1,502,217 | 0.0% | 0.20% | +15.3% |
| Q1 2019 | $24,921,000 | +18.2% | 1,502,217 | 0.0% | 0.18% | -1.1% |
| Q4 2018 | $21,091,000 | -19.8% | 1,502,217 | 0.0% | 0.18% | -5.3% |
| Q3 2018 | $26,288,000 | +56.0% | 1,502,217 | +62.2% | 0.19% | +41.4% |
| Q2 2018 | $16,853,000 | – | 925,996 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,807,982 | $59,049,000 | 6.41% |
| ACUTA CAPITAL PARTNERS, LLC | 637,500 | $20,821,000 | 5.67% |
| Asymmetry Capital Management, L.P. | 346,518 | $11,317,000 | 5.16% |
| Affinity Asset Advisors, LLC | 260,000 | $8,492,000 | 4.50% |
| EcoR1 Capital, LLC | 1,773,037 | $57,907,000 | 3.11% |
| VR Adviser, LLC | 575,000 | $18,780,000 | 2.76% |
| COMMODORE CAPITAL LP | 133,503 | $4,360,000 | 2.37% |
| Ghost Tree Capital, LLC | 325,000 | $10,615,000 | 2.36% |
| Avoro Capital Advisors LLC | 4,000,000 | $130,640,000 | 2.25% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 90,000 | $2,939,000 | 1.71% |